Growth Metrics

Celularity (CELU) Gains from Investment Securities (2020 - 2025)

Celularity (CELU) has disclosed Gains from Investment Securities for 6 consecutive years, with -$2.0 million as the latest value for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 139.13% year-over-year to -$2.0 million; the TTM value through Dec 2025 reached $3.7 million, up 1015.24%, while the annual FY2025 figure was $3.8 million, 1055.78% up from the prior year.
  • Gains from Investment Securities hit -$2.0 million in Q4 2025 for Celularity, down from $4.3 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $104.4 million in Q4 2023 and bottomed at -$43.2 million in Q2 2022.
  • Average Gains from Investment Securities over 5 years is $4.9 million, with a median of $75500.0 recorded in 2023.
  • Year-over-year, Gains from Investment Securities surged 36539.6% in 2021 and then crashed 5327.61% in 2024.
  • Celularity's Gains from Investment Securities stood at -$23.3 million in 2021, then soared by 54.95% to -$10.5 million in 2022, then soared by 1095.05% to $104.4 million in 2023, then crashed by 100.79% to -$828000.0 in 2024, then plummeted by 139.13% to -$2.0 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$2.0 million, $4.3 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.